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The 1st World Congress on Gender-Specific Medicine
Men, Women and Medicine
A New View of the Biology of Sex/Gender Differences 
and Aging
 The 1st World Congress on Gender-Specific 
Medicine, Gender-Based Differences and Aging 
took place in Berlin, February 23-26, 2006. There 
were presentations on Gender-specific aspects of 
cardiovascular diseases; Gender and the treat-
ment of diseases; The gender-specific experience 
of pain; Immunology – the role of gender; The im-
pact of biological sex/gender on metabolism; Gen-
der and dermatology; Gender and sexual function; 
Gender medicine around the world; Gender and 
aging; The gender-specific brain; The role of tes-
tosterone in the metabolic syndrome in men; Gen-
der-specific aspects of drug metabolism and ad-
diction; The lung: development, malignancy and 
gender; Building a gender-specific medical center: 
pointers and pitfalls; and the impact of sex on ill-
ness. It was an honor for me to be invited and to 
present our experience and differences between 
men and female contact allergy. 
 Here are some of the newest concepts: women 
live longer than men. Male and female hearts re-
spond differently to pressure load and may also 
differ in their metabolic response. In Europe, car-
diovascular diseases kills a higher percentage of 
women (55%) compared to men (45%). Women in 
general have more adverse side effects and drug 
interactions. Women in cardiology are under-diag-
nosed, under-represented and under-researched. 
Diabetes mellitus in women produces a 4 to 6-fold 
increase in the risk of coronary artery disease, 
while men experience only a doubling of risk. In 
cardiac surgery outcome, women had a 1.5-fold 
(p<0.001) age-dependent early all-cause mortal-
ity rate recorded in men, identifying the gender-
specific risk factors. The focus of research on 
women’s health has evolved during the past 15 
years. Clinical studies include women, now requir-
ing that the research defines differences between 
men and women and that sex/gender differences 
be addressed in the design of biomedical re-
search, including basic biological studies. Detec-
tion of gender genomic ID-clock information has 
been a longstanding unfulfilled dream in medicine. 
Biotechnology approach can translate functional 
genomics into gender time-mapped pharmacoge-
nomic personalized medicine, new therapeutic 
targets and drug discovery. Gender maps of time-
keeping patterns may serve for timing, screening, 
diagnosis and an improved quality of life in men 
and women along their lifespan. The overall prev-
alence of migraine in the western world is approxi-
mately 10%, affecting only 6% of men and 18% of 
women. What is the role of feminine hormones and 
how to treat migraine? Epidemiological evidence 
suggests gender differences in the prevalence 
and blood pressure levels in different age groups. 
Obesity is an important contributor to hypertension 
in females, and psychosocial aspects may affect 
blood pressure levels differently in men and wom-
en. In many types of kidney diseases, progression 
is faster in men than in women. There is growing 
evidence for anatomical and neuropsychological 
differences in the nociceptive system of males and 
females: sex differences in perceptual sensitivity 
have been documented. Sexual dimorphism in no-
ciceptive processing and pain responses involves 
the interactions of multiple biological, psychologi-
cal, and sociocultural factors. Most autoimmune 
diseases are detected in females of childbearing 
age. The role of estrogens will be delineated. Pro-
lactin also plays a role in autoimmunity. Hormonal 
factors regulate immunity and affect susceptibil-
ity to autoimmune/inflammatory disease. Regula-
tion of immunity by and interactions between the 
hypothalamic-pituitary-adrenal (HPA) and hypo-
thalamic-pituitary-gonodal (HPG) axes contrib-
ute to the two- to tenfold incidence and severity 
of autoimmune/inflammatory diseases in females 
compared to males. Some of asthmatic women 
also have worsening symptoms before or during 
menstruation. PPARg is a member of the nuclear 
hormone receptor superfamily that regulates lipid 
metabolism and glucose homeostasis. The inci-
dence of side effects of PPARg in the treatment of 
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diabetes is much higher in females than in males; 
PPARg expression was higher in females and es-
trogen enhanced PPARg. Estrogen receptors are 
thought to play a crucial role in development, re-
production, and normal physiology. They activate 
the immune system in a more complex manner: 
T helper 1 responses are ameliorated while T 
helper 2 responses are induced or accelerated. 
Data were presented on gender specific derma-
toses, the basic immune endocrine interplay that 
guides the immunomodulatory effects of sex hor-
mones, and the molecular mechanism of action of 
these hormones through cellular receptors. Sex 
steroids have different effects on the development 
and function of the immune system in men and 
women, resulting in dimorphism: women show a 
greater immune response to exogenic insults and 
stronger autoimmune reactions than men. An in-
crease in oxidative stress has been described dur-
ing intensive physical exercise. Gender differences 
have been recorded in oxidative stress, especially 
at older age. Parenteral expression is among most 
consistent and well-replicated risk factors for child-
hood anxiety disorders, disruptive disorders and 
depression. The results support active treatment 
of depressed mothers, as the impact is not only on 
themselves but also on their children. The result 
needs to be examined in depressed fathers. Gen-
der-biased practice in cardiology was one of the 
first areas focused on by researchers in gender-
specific medicine. Coronary artery disease (CAD) 
is the leading cause of death in postmenopausal 
women. At age <55, the incidence of CAD is one-
third that in men, however, by age 75 this gender 
gap disappears. Female gender is an independent 
risk factor for early mortality after bypass surgery 
in patients aged <70.5. 
 Screening studies of sleep apnea in the gen-
eral population (Canada) found the prevalence to 
be actually less disproportionate (M:F=2:1). An in-
creased prevalence of sleep apnea was recorded 
in men. Dementia is an increasing common dis-
ease. As women in many countries outlive men, 
their risk of dementia also rises, as age is the 
greatest risk factor for dementia (Canada). The 
main risk factors for dementia are age, family his-
tory, apo E status, and the traditional vascular risk 
factors such as hypertension, diabetes, hypercho-
lesterolemia, and atrial fibrillation. The metabolic 
syndrome triade is a significant predictor of type 
2 diabetes as well as of atherosclerotic vascular 
disease. Visceral obesity, insulin resistance, and 
low-grade inflammation are the major components 
that act through a vicious cycle of sex-based dif-
ferences in the pharmacokinetics and pharmaco-
dynamics, well known for years now. Women suf-
fer more frequently from adverse drug reactions 
than men, e.g., metoprolol induced bradycardia, 
morphine-associated nausea, and meploquine-in-
duced psychosis. Especially QT-prolongation oc-
curs more frequently in women then in men.
 Women smokers are much more likely to have 
bronchial hyperreactivity than men, and it cor-
relates with a faster decline of lung function in 
women but not in men. Many more women than 
men suffer from migraine and temporomandibular 
pain. Studies (USA) suggest that estrogen recep-
tors in trigeminal neurons modulate nociceptive 
responses through serotonin and neuropeptides. 
Variation in estrogen receptor signaling and neu-
ropeptide plasticity in trigeminal neurons across 
the female cycle may be the major contributor to 
the increase of painful episodes in specific phases 
of the menstrual cycle. Musculoskeletal pain (MP) 
comprises a major public health problem in west-
ern countries, mainly due to its high impact on 
(work) disability. Pain was more prevalent among 
women than among men. Overweight (all pain 
locations) and older age (lower extremities) was 
more strongly associated with chronic MP in wom-
en while pain catastrophizing (upper extremities) 
was more strongly associated with chronic MP in 
men.
 The development of gender-specific medicine 
as a field is a triumph for evidence based medicine 
and equity advocacy, and is a credit to founders 
(Australia). Women experience more nausea and 
vomiting than men in a variety of clinical and non-
clinical conditions. Sexual dysfunction is common-
ly understood as a psychosomatic disorder with 
psychodynamic as well as organic background. 
Essential hypertension is a widespread and com-
mon disorder. Hypertension and sexual dysfunc-
tion are a high risk for men but not for women. 
Gender is more than biological differences be-
tween women and men. A gender perspective in 
medicine implies that living conditions, positions 
in the society, and societal expectations about 
“femininity” and “masculinity” are to be considered 
along with biology in professional relations as well 
as when theorizing about women and men. On an 
average, men experience ischemic heart disease 
approximately ten years before women. Identifica-
tion of y chromosome CVD risk genes may lead 
to elucidation of the CVD risk for men. Chronic 
pain changed hormonal plasma levels differently 
in male and female patients. The macrophage mi-
gration inhibitory factor (MIF) showed positive cor-
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relation with testosterone and negative correlation 
with estradiol. In younger men and women there is 
a strong pain-induced decrease in MIF availability. 
Cytosine-adenine repeat polymorphism of the es-
trogen receptor beta (Erb) gene may be associated 
with menopausal symptoms. Twenty percentage 
of mortality in western population is due to cancer; 
40% are involved at some point during life. Most 
cancer forms show conspicuous difference in the 
frequencies between women and men. Lung can-
cer is the most common cancer worldwide, and 
the most common cause of cancer-related deaths 
in western countries. Since 1950, lung cancer 
rates have increased by 50% in women. In 2005, 
approximately 25% of female deaths could be at-
tributed to lung cancer. 
 Gender-specific medicine has major responsi-
bility to meet social needs and to contribute to the 
social value of health research. This meeting was 
successful for both attendees and presenters.
  
  Professor Jasna Lipozenčić, MD, PhD
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Disease Control Priorities Project (DCPP) and 2nd Global 
Meeting of the Inter-Academy Medical Panel (IAMP)
April 2-6, 2006
Beijing, China
 On behalf of the Disease Control Priorities 
Project (DCPP), the Inter-Academy Medical Pan-
el (IAMP), the Chinese Academy of Engineering 
(CAE) and the Chinese Academy of Sciences 
(CAS), Launch was held in conjunction with the 
2nd Global Meeting of the IAMP, April 2-6, 2006, 
Beijing, China.
 Over 300 policymakers, international health 
experts, journalist, and scientists were invited to 
this landmark event. The program informed global 
audience on the importance of setting well-defined 
health priorities and implementing cost-effec-
tive, evidence-based interventions. In addition to 
stimulating dialogue among attendees including a 
large number of Chinese scientists, the event was 
highly publicized and covered by international me-
dia to reach global audience. DCPP is a partner-
ship among the Fogarty International Center of the 
U.S. National Institutes of Health, the World Bank, 
the World Health Organization, and the Popula-
tion Reference Bureau, with funding from the Bill 
& Melinda Gates Foundation.
 The DCPP portion of the program highlighted 
policy implications of three flagship publications: 
Disease Control Priorities in Developing Countries, 
Second Edition (DCP2), featuring a cost-effective-
ness analysis of health interventions, health-sys-
tems, and prevention and treatment programs for 
a comprehensive range of diseases and condi-
tions; Global Burden of Disease and Risk Factors, 
a compendium of world-wide deaths by cause, 
burden of disease, and risk factor data; Priorities 
in Health, a distillation of DCP2 written for policy-
makers; it is available in seven languages.
 The books provide flexible, practical and simple 
tools to assist countries to reach the Millennium 
Development Goals for Health (MDGs), among 
other health and development outcomes.
 The 2nd Global Meeting of the IAMP featured in-
depth presentations and discussions of the DCPP 
scientific content and related topics such as avian 
influenza and road traffic safety. Members of the 
IAMP (Academy of Medical Sciences of Croatia is 
member since 2001), an international coalition of 
academies of medicine, engineering and scienc-
es, serve as Advisory Committee to the Editors of 
DCPP. The Academy of Medical Sciences of Cro-
atia was represented by Professor J. Lipozenčić 
at General Assembly on April 6, 2006. It was very 
useful to attend this Meeting, the main messages 
of which will be presented to 192 health ministers 
at the World Health Assembly in May in Geneva.
  
Professor Jasna Lipozenčić, MD, PhD
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